pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics research.
TCR - T cell receptor
TCR characterization
TCR-seq
computational notebooks
immunogenomics
reproducibility
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
26
05
2022
accepted:
05
10
2022
entrez:
1
12
2022
pubmed:
2
12
2022
medline:
3
12
2022
Statut:
epublish
Résumé
T cell receptor (TCR) studies have grown substantially with the advancement in the sequencing techniques of T cell receptor repertoire sequencing (TCR-Seq). The analysis of the TCR-Seq data requires computational skills to run the computational analysis of TCR repertoire tools. However biomedical researchers with limited computational backgrounds face numerous obstacles to properly and efficiently utilizing bioinformatics tools for analyzing TCR-Seq data. Here we report pyTCR, a computational notebook-based solution for comprehensive and scalable TCR-Seq data analysis. Computational notebooks, which combine code, calculations, and visualization, are able to provide users with a high level of flexibility and transparency for the analysis. Additionally, computational notebooks are demonstrated to be user-friendly and suitable for researchers with limited computational skills. Our tool has a rich set of functionalities including various TCR metrics, statistical analysis, and customizable visualizations. The application of pyTCR on large and diverse TCR-Seq datasets will enable the effective analysis of large-scale TCR-Seq data with flexibility, and eventually facilitate new discoveries.
Identifiants
pubmed: 36451811
doi: 10.3389/fimmu.2022.954078
pmc: PMC9704496
doi:
Substances chimiques
Receptors, Antigen, T-Cell
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
954078Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR001854
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA248381
Pays : United States
Informations de copyright
Copyright © 2022 Peng, Moore, Vahed, Brito, Kao, Burkhardt, Alachkar and Mangul.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Immunol. 2021 Aug;41(6):1131-1145
pubmed: 33950324
Cell Discov. 2021 Sep 28;7(1):89
pubmed: 34580278
Front Immunol. 2019 Aug 21;10:1897
pubmed: 31497012
Front Genet. 2020 Jul 21;11:771
pubmed: 32849789
Ann Rheum Dis. 2019 Aug;78(8):1070-1078
pubmed: 31101603
Cancer Immunol Res. 2019 Jan;7(1):77-85
pubmed: 30425105
Nat Genet. 2017 May;49(5):659-665
pubmed: 28369038
Front Immunol. 2022 Jan 27;13:807696
pubmed: 35154125
Cell. 2017 Feb 9;168(4):600-612
pubmed: 28187283
PLoS Comput Biol. 2015 Nov 25;11(11):e1004503
pubmed: 26606115
PLoS One. 2016 Nov 11;11(11):e0166126
pubmed: 27835690
Semin Immunopathol. 2017 Apr;39(3):255-268
pubmed: 28074285
Nature. 2020 Jan;577(7790):399-404
pubmed: 31915375
Signal Transduct Target Ther. 2020 Aug 14;5(1):156
pubmed: 32796814
PLoS Biol. 2019 Jun 20;17(6):e3000333
pubmed: 31220077
Front Immunol. 2018 Feb 20;9:291
pubmed: 29515587